August 4, 2017
Lundbeck A/S and 23andMe Inc. are working together on a massive study analyzing the role genetics play in depression. Along with the Milken Institute, they plan […]
August 18, 2017
Johnson & Johnson CEO Alex Gorsky decided to leave President Trump’s manufacturing council. The decision came about the same time Trump ended the panel. Both actions […]
August 21, 2017
During her presidential campaign, Hillary Clinton brought Turing Pharmaceuticals’ overnight price hike for Daraprim into the spotlight, implying that drug pricing could soon be a main […]
August 21, 2017
President Trump declared the opioid crisis a national emergency. This follows the release of the White House Opioid Commission’s Interim Report, which recommended the President declare […]
August 21, 2017
LabCorp, a provider of clinical laboratory products and services, is acquiring CRO Chiltern International in order to scale up their life science capabilities. The deal […]
September 1, 2017
The FDA approved the first CAR-T therapy, Novartis AG’s Kymriah, on Wednesday. This treatment had remarkable results in children with an aggressive form of leukemia resistant […]
September 22, 2017
The FDA approved Amgen and Allergan’s biosimilar version of Roche’s Avastin, the first time they’ve approved a copycat biologic of a cancer drug. Amgen’s biosimilar, Mvasi, […]
October 16, 2017
Bruce Booth, Forbes Contributor and partner at Atlas Venture, was struck by the recent analysis of Big Pharma by Citi that looked at the average and […]
October 16, 2017
When choosing the Fierce 15, FierceBiotech looks for the best science combined with the best management teams. But the key issue is the future. Could their […]